Morgan Stanley analyst Joseph Moore raised the firm’s price target on Astera Labs (ALAB) to $240 from $210 and keeps an Overweight rating on the shares. Astera is executing at a high level, with Scorpio driving near-term growth, and with rising content per XPU, early PCIe Gen 6 leadership, and future upside from optical and custom solutions, the company “remains well positioned for sustained AI infrastructure growth,” the analyst tells investors.
Claim 55% Off TipRanks
New trading tool for ALAB bullsPublished first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALAB:
- Quinn Bolton Lifts Astera Labs Price Target to $260 on Strong Product Momentum and Long-Term AI Growth Drivers
- Astera Labs Earns Buy Rating on Strong Q1 Results, Surging Scorpio AI Switch Demand, and Expanding Connectivity Portfolio
- Sean O’Loughlin Reiterates Hold on Astera, Lifts Price Target to $225 Amid Strong Near-Term Upside but Longer-Term Competitive Uncertainty
- Astera Labs’ Earnings Call Highlights Explosive AI Growth
- Astera Labs Inc options imply 11.1% move in share price post-earnings